(Q39534691)

12 September 2017

title

Is orphan drug status beneficial to tropical disease control? Comparison of the American and future European orphan drug acts (English)

1 reference

12 September 2017

1 reference

P Trouiller

1

1 reference

12 September 2017

C Battistella

series ordinal

2

1 reference

12 September 2017

J Pinel

series ordinal

3

1 reference

12 September 2017

B Pecoul

series ordinal

4

1 reference

12 September 2017

publication date

1 June 1999

1 reference

Tropical Medicine and International Health

12 September 2017

published in

1 reference

12 September 2017

volume

4

1 reference

12 September 2017

issue

6

1 reference

12 September 2017

page(s)

412-420

1 reference

The effect of pharmacoeconomics on company research and development decisions

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00420.X

Returns to R&D on new drug introductions in the 1980s

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00420.X

Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00420.X

Will the fight against tropical diseases benefit from orphan drug status?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00420.X

Access to essential drugs in poor countries: a lost battle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00420.X

The fall and rise of sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00420.X

10.1046/J.1365-3156.1999.00420.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference